Ernest Pharmaceuticals LLC has developed a therapeutic platform based on therapeutic bacteria, designed with synthetic techniques. The microbial genome is highly plastic and malleable. Reconfiguration of biological components enables bottom-up design of novel therapeutic tools. Many anticancer compounds exist in the biological world. By taking cues from the living systems, rational design of bacterial genetics will create biomedical tools that are safe and effective at treating human disease.
